PRT7732
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRT7732, covering 2026-02-02 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]